3,4-dihydroxyphenylacetic acid has been researched along with caffeine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Zielke, CL; Zielke, HR | 1 |
| Hadfield, MG; Milio, C | 1 |
| Uramoto, H; Watanabe, H | 1 |
| Battaini, F; Govoni, S; Missale, C; Montefusco, O; Petkov, VV; Spano, PF; Trabucchi, M | 1 |
| Hadfield, MG | 1 |
| Beilstein, M; Castagnoli, K; Castagnoli, N; Chen, JF; Petzer, JP; Schwarzschild, MA; Sonsalla, PK; Staal, R; Xu, K; Xu, YH | 1 |
| Conney, AH; Lou, YR; Lu, YP; Michna, L; Wagner, GC | 1 |
| Dziubina, A; Gołembiowska, K | 3 |
| Ascherio, A; Brown-Jermyn, D; Chen, JF; Dluzen, DE; Schwarzschild, MA; Xu, K; Xu, Y | 1 |
| Barbanoj, M; Kulisevsky, J; Pérez, V; Rodríguez-Alvarez, J; Rubio, A; Sosti, V | 1 |
| Chiu, TH; Hsu, CW; Wang, CS | 1 |
| Cavalheiro, EA; Cerqueira, GS; Correia, AO; de Barros Viana, GS; de Castro Brito, GA; Machado-Filho, JA; Montenegro, AB; Naffah-Mazzacoratti, Mda G; Neves, KR; Nobre, ME | 1 |
15 other study(ies) available for 3,4-dihydroxyphenylacetic acid and caffeine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Lack of a sustained effect on catecholamines or indoles in mouse brain after long term subcutaneous administration of caffeine and theophylline.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Caffeine; Cerebellum; Cerebral Cortex; Chromatography, High Pressure Liquid; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Hypothalamus; Injections, Subcutaneous; Male; Mice; Mice, Inbred DBA; Norepinephrine; Serotonin; Theophylline | 1986 |
Caffeine and regional brain monoamine utilization in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Biogenic Monoamines; Brain; Brain Mapping; Caffeine; Chromatography, High Pressure Liquid; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred ICR; Neurotransmitter Agents; Norepinephrine; Serotonin | 1989 |
Caffeine mimics dopamine receptor agonists without stimulation of dopamine receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Caffeine; Corpus Striatum; Dopamine; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Theophylline | 1986 |
Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Caffeine; Dose-Response Relationship, Drug; Male; Phenylacetates; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1984 |
Caffeine and the olfactory bulb.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Brain; Caffeine; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Hippocampus; Hypothalamus; Male; Mice; Mice, Inbred ICR; Norepinephrine; Olfactory Bulb; Organ Specificity; Receptors, Purinergic P1; Serotonin; Thalamus | 1997 |
Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Caffeine; Catechols; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Immunity, Innate; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Parkinsonian Disorders; Purinergic P1 Receptor Antagonists; Purines; Pyrimidines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Theobromine; Triazoles; Xanthines | 2001 |
Stimulatory effect of oral administration of green tea and caffeine on locomotor activity in SKH-1 mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adipose Tissue; Animals; Body Weight; Brain Chemistry; Caffeine; Dopamine; Drinking; Eating; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Mice; Mice, Hairless; Motor Activity; Muscles; Photoperiod; Serotonin; Tea | 2003 |
Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Benserazide; Brain Chemistry; Caffeine; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Male; Microdialysis; Rats; Rats, Wistar; Reserpine | 2004 |
Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Caffeine; Corpus Striatum; Cytochrome P-450 CYP1A2; Dopamine; Drug Implants; Estradiol; Estrogen Replacement Therapy; Female; Male; Methylation; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Ovariectomy; Parkinsonian Disorders; Sex Characteristics | 2006 |
Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Benzylamines; Brain; Caffeine; Dopamine; Dopamine Agents; Homovanillic Acid; Levodopa; Male; Motor Activity; Neurotoxins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2007 |
Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Dopamine; Homovanillic Acid; Male; Mice; Mice, Inbred BALB C; Neostriatum; Neuroprotective Agents; Phosphorylation; Pyrimidines; Serine; Triazoles; Tyrosine 3-Monooxygenase; Xanthines | 2010 |
Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Animals; Benserazide; Caffeine; Dopamine; Glutamic Acid; Hydroxyl Radical; Levodopa; Male; Microdialysis; Neostriatum; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazines; Triazoles | 2012 |
The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenosine A2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Caffeine; Corpus Striatum; Dopamine; Dopamine Agents; Extracellular Space; Glutamic Acid; Homovanillic Acid; Hydroxyl Radical; Levodopa; Male; Microdialysis; Oxidative Stress; Rats; Rats, Wistar; Reserpine; Triazines; Triazoles; Vesicular Monoamine Transport Proteins | 2012 |
Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Apomorphine; Brain; Caffeine; Cytokines; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Exploratory Behavior; Histone Deacetylases; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2014 |